Article
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.
Breast cancer research and treatment - 1 Nov 2011
Fuchs-Young Robin, Shirley Stephanie H, Lambertz Isabel, Colby Jennifer K L, Tian Jie, Johnston Dennis, Gimenez-Conti Irma B, Donehower Lawrence A, Conti Claudio J, Hursting Stephen D
Abstract excerpt
Clinical studies show that estrogen receptor-α (ER) expressing tumors tend to have better prognosis, respond to antiestrogen therapy and have wild-type p53. Conversely, tumors with inactivating mutations in p53 tend to have worse outcomes and to be ER-negative and unresponsive to antihormone treatment. Previous studies from our laboratory have shown that p53 regulates ER expression transcriptionally, by binding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.